Development of olmesartan medoxomil optimized nanosuspension using the Box–Behnken design to improve oral bioavailability

K. Nagaraj, D. Narendar, V. Kishan
  • Drug Development and Industrial Pharmacy, March 2017, Taylor & Francis
  • DOI: 10.1080/03639045.2017.1304955

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/03639045.2017.1304955

The following have contributed to this page: Narendar Dudhipala and Kishan Veerabrahma

In partnership with: